• Prof Axel Heidenreich

    Oncology (Prostate)/University of Cologne, Germany

  • Axel Heidenreich is Professor of Urology and Chairman and Director of the Department of Urology, Uro-Oncology, Robot-Assisted and Specialized Urologic Surgery at the University Hospital in Cologne Germany. Previously, he was the Chairman and Director of the Department of Urology of the University Hospital, RWTH Aachen, Germany from 2009 to 2015. He received his medical degree from the University of the Health Sciences in San Antonio, Texas, USA and the Johannes Gutenberg University in Mainz, Germany. He underwent his residency training program at the University Hospital in Cologne, Germany and he underwent a Clinical and Research Fellowship at the Armed Forces Institute of Pathology and the Department of Urology, Walter Reed Army Medical Centre, Washington, DC, USA.

    Prof Heidenreich’s main interests are in surgical and conservative uro-oncology with emphasis on prostate and testis cancer and plastic/reconstructive surgery. He focuses very much on complex surgeries such as postchemotherapy RPLND, salvage radical prostatectomies, IVC thrombus surgery and radical cystectomies etc. He also conducts basic research in the molecular pathogenesis and prognosis of urological malignancies and has acted as principal investigator in multiple clinical trials. He has published over  430 original manuscripts in peer-reviewed journals, he has edited 16 books and he contributed more than 115 book chapters.

    Prof Heidenreich has served as the Chairman of both the Prostate Cancer Guideline Working Group of the European Association of Urology (EAU) from 2007 to 2014, the German Testicular Cancer Study Group, and the German Working Group on Castration-Resistant Prostate Cancer and is a Board Member of the European Society for Oncological Urology of the EAU and the Association of Urological Oncology of the German Cancer Society.

    Prof Heidenreich has received many scientific awards, including the Nietze and BARD awards from the German Society of Urology, the uro-oncology award from EAU and the Paul-Mellin award from the North Rhine-Westphalia Society of Urology. Prof Heidenreich has received many honorary memberships of International Urology Societies and International Universities.

    Supported by: